| HOME >> BIOLOGY >> TECHNOLOGY |
HUBBARD, Ohio, Aug. 27 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX) is pleased to announce that Chris R. Novak, Esq. has joined the company as Director of Intellectual Property. In addition, we wish to announce that major advances have been made in the rapid detection of Anthrax utilizing the NanoLogix BioNanoChannel(TM) Device.
Mr. Novak has over seven years' experience as an intellectual property counsel in a wide range of high tech industries including the position of Corporate Intellectual Property Counsel of IDT (Integrated Device Technology, Inc.), a NASDAQ 100 semiconductor company with sales of over $800 million a year. Mr. Novak has a Bachelor of Science in Mechanical Engineering and a Juris Doctorate, both awarded by Marquette University. He also holds a Master of Science Degree in Electrical Engineering from Cal Poly State University. Mr. Novak is licensed for the practice of law in California, Colorado, and Wisconsin and the United States Patent and Trademark Office (USPTO) and is preparing for admission to the Ohio Bar. In addition to his experience as a patent attorney, Mr. Novak worked as an engineer for high-tech companies for ten years.
"Mr. Novak will represent NanoLogix as our dedicated intellectual property counsel and manage the expansion and protection of our technologies through patents and other methods. NanoLogix's key asset value is its impressive intellectual property portfolio," said Vice President of Strategic Partnering, Dana Allen. "We are pleased to welcome Chris to the Company in this newly- created role."
"I believe the revolutionary and practical ideas being developed at NanoLogix will have a major impact on the biotechnology and energy fields," said Director of IP Chris Novak, Esq. "We plan to protect these ideas to the fullest extent, and turn these ideas into marketplace realities that will sharply increase revenues."
In another significant development, Nanologix has been working on a
requ
'/>"/>
| SOURCE NanoLogix, Inc. Copyright©2007 PR Newswire. All rights reserved |